Most side effects are mild and temporary, especially when your dose is adjusted gradually
(.) GLP-1 receptor agonists (GLP-1 RA) Semaglutide, Liraglutide, Dulaglutide, Lixisenatide Tirzepatide 2 ()
Importantly, the underlying cell death mechanism is triggered by CBS inhibition in HepG2 cells via ferroptosis, suggesting that CBS has a previously unreported function in this process
Progress is monitored over time, with adjustments made as needed to support safety, tolerance, and effectiveness
This may lead individuals to seek alternative medications or treatments that are more affordable
These findings suggested that inhibiting ATF2 or NRF2 may enhance BET-induced ferroptosis, thereby augmenting the anticancer effects of BETi